Tracheal adenoid cystic carcinoma: A reported case and review of literature. | ||||
The Egyptian Journal of Surgery | ||||
Volume 43, Issue 4, October 2024, Page 1603-1607 PDF (595.57 K) | ||||
Document Type: Case Report | ||||
DOI: 10.21608/EJSUR.2024.286185.1059 | ||||
![]() | ||||
Author | ||||
Omar Iskanderani ![]() ![]() | ||||
Department of Radiation Oncology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia | ||||
Abstract | ||||
remains the primary treatment, but optimal postoperative radiotherapy regimens are still being explored to minimize local recurrence. This is a case of ACC of the trachea. An individualized radiotherapy regimen was meticulously planned after surgery. This tailored approach significantly impacted the patient’s outcomes. Case Report: A 49-year-old female with history of progressive dyspnea and cough that was unresponsive to conventional treatments over 6 months. Flexible bronchoscopy revealed an obstructing mass in the upper trachea, and biopsy confirmed the diagnosis of adenoid cystic carcinoma. Imaging ruled out distant metastases. The patient underwent tracheal sleeve resection, followed by adjuvant radiation therapy using Volumetric Modulated Arc Therapy (VMAT) and 6-megavoltage (MV) radiography. The patient tolerated the treatment well, with no significant acute or late toxicities. Follow-up imaging studies have shown no evidence of recurrence at 6 years post-treatment. Conclusion: Tracheal ACC is a rare but distinct entity that requires prompt recognition and multimodality management for optimal outcomes. | ||||
Keywords | ||||
Adenoid cystic carcinoma; malignancy; trachea | ||||
Statistics Article View: 74 PDF Download: 92 |
||||